Open AccessDrug Discovery and Development Strategies for COVID-19
Author(s) -
Aarajana Shrestha,
Tara Man Kadayat
Publication year - 2020
Publication title -
europasian journal of medical sciences
Language(s) - English
Resource type - Journals
eISSN - 2717-4654
pISSN - 2717-4646
DOI - 10.46405/ejms.v2i2.89
Subject(s) - covid-19 , drug development , drug discovery , cover (algebra) , engineering ethics , coronavirus infections , drug approval , disease , data science , medicine , political science , drug , computer science , virology , infectious disease (medical specialty) , engineering , pharmacology , bioinformatics , biology , outbreak , mechanical engineering , pathology
COVID-19 Special Issue: Coronavirus Disease 2019 (COVID-19) has emerged as a global threat. Scientists and clinicians are endeavoring to find effective drugs and vaccines for this disease. This special issue of the Europasian Journal of Medical Sciences (EJMS) aims to cover the problems, solutions, and challenges of COVID-19 around the world. In this Editorial, EJMS Editors Aarajana Shrestha and Tara Man Kadayat highlight the processes of drug discovery and development and a brief overview of the current drug development strategies against COVID-19.